Plasma Kallikrein Inhibitor [EPC]

2398 reported adverse events

Drugs of this class: ECALLANTIDE LANADELUMAB-FLYO SEBETRALSTAT

These side effects are most commonly reported by patients taking drugs of the Plasma Kallikrein Inhibitor [EPC] class:

# Side effect Count
0 HEREDITARY ANGIOEDEMA 991
1 DRUG INEFFECTIVE 249
2 OFF LABEL USE 184
3 HEADACHE 120
4 MALAISE 98
5 PRODUCT DOSE OMISSION ISSUE 91
6 WEIGHT DECREASED 85
7 NAUSEA 82
8 PAIN 81
9 WEIGHT INCREASED 79
See all common reactions for Plasma Kallikrein Inhibitor [EPC]

Drugs of the Plasma Kallikrein Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEREDITARY ANGIOEDEMA 991 0.0923
1 HTLV TEST POSITIVE 1 0.0909
2 UNADJUSTED DOSE ADMINISTERED 6 0.0882
3 ABSCESS OF EXTERNAL EAR 1 0.0833
4 FAILED EXAMINATIONS 1 0.0588
5 LARGE CELL LUNG CANCER METASTATIC 1 0.0588
6 CHEILITIS GRANULOMATOSA 1 0.0417
7 EXPOSURE TO HOUSEHOLD CHEMICALS 1 0.0294
8 COMPLEMENT DEFICIENCY DISEASE 1 0.0270
9 ENDOMETRIAL CANCER STAGE II 1 0.0233
See all enriched reactions for Plasma Kallikrein Inhibitor [EPC]